Figure 2AFrom: Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities12-lead ECG sampling pattern in the run-in period (baseline). Minimum number of recordings are highlighted at 8, 14 and 20 hours. Figure 2B Plasma concentration-time profiles (PK/PD analysis).Back to article page